K-Beauty Market Strategy and Organic Cosmetic Regulations

FREE
Christine Kim
Thursday , 4th Jun 2020
K-GMP Co., Ltd.
Background

In this webinar, we will analyze and interpret the new cosmetic regulations released by The Korean MFDS (Ministry of Food and Drug Safety) related to organic cosmetic products. In addition to regulatory guidance on organic cosmetics, during this webinar, we will introduce beauty trends in 2020 and strategies for K-Beauty marketing. By sharing our analysis of popular products, package design, promotion, commercial, and distribution channels, we aim to help stakeholders understand K-Beauty.

*Due to the modification of Zoom rules, this webinar requires a password to participate. Please find the password in the email sending the participation link. If you do not receive the email after registration, please contact ChemLinked.

Contents

Part 1 MFDS REGULATION ON ORGANIC COSMETICS

    Introduction of MFDS regulation on organic cosmetics 

Part 2 K-BEAUTY 2020 TREND

    Market Overview, Popular Products, and HOT Trend of K-Beauty.

Part 3 K-BEATY MARKETING STRATEGY

    Promotion, Commercial, and distribution channels of K-Beauty

Schedule
Date Time (GMT+8) World Clock Language
2020-06-04 10:00 ~ 11:00 Melbourne: 12:00-13:00 English
21:00 ~ 22:00 Paris: 15:00-16:00 New York: 9:00-10:00 English
* Same content in different sessions to facilitate the attendance of audiences from different time zones.
Contact Information

If you have any questions about this webinar, please contact us at:

EMAIL: contact@chemlinked.com

TEL: +86 (0) 571 8609 4444

Speaker
  • CEO & Regulatory affairs specialist
    Christine has broad experience in trade policy, MFDS(South Korea), Europe, U.S. FDA and global regulations regarding Food, Cosmetic, Medical device and drug. She constantly shares her insights on hygiene-related regulation updates, and has helped many domestic and overseas stakeholders in food, cosmetic, medical device and drug industry comply with standards. Her expertise is mainly in food, cosmetics, medical device and drug regulation and trade policy.